Comprehending Atopic Risk Elements
NCT04325451 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 252
Last updated 2022-11-03
Summary
Skin barrier impairment and familial atopy have been implicated as crucial risk factors for the development of atopic dermatitis (AD). Additional risk factors have been explored, including gestational weight, height, age, familial smoking habits, proximity to urban centers and others. However, a comprehensive study focusing on the entire spectrum of risk factors has yet to be undertaken. Such a study could enable predictive capabilities able to inform medical professionals as to a newborn's inherent risk to develop AD, and potentially recommend appropriate preventative modalities to prevent or delay disease onset.
Conditions
Sponsors & Collaborators
-
Meir Medical Center
collaborator OTHER -
The Baruch Padeh Medical Center, Poriya
collaborator OTHER_GOV -
MYOR Ltd.
lead INDUSTRY
Principal Investigators
-
Tatiana Smolkin, MD · Poriah Medical Center
-
Tzofia Bauer, MD · Meir Medical Center
Eligibility
- Min Age
- 24 Hours
- Max Age
- 120 Hours
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-06-03
- Primary Completion
- 2023-05-01
- Completion
- 2024-05-01
Countries
- Israel
Study Locations
More Related Trials
-
Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)
NCT03849716 ·Status: ACTIVE_NOT_RECRUITING
-
Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit
NCT00654355 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis
NCT02347176 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Topical Coal Tar in Children With Atopic Dermatitis
NCT03461302 ·Status: UNKNOWN ·Phase: PHASE4
-
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
NCT07290803 ·Status: RECRUITING
-
Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis
NCT01782703 ·Status: ACTIVE_NOT_RECRUITING
-
Moisturizer to Prevent Atopic Dermatitis
NCT03808532 ·Status: WITHDRAWN ·Phase: PHASE2
-
Asthma, Missed Immunizations, and Vitamin D Deficiency in Atopic Dermatitis
NCT01234909 ·Status: TERMINATED
-
Prospective Longitudinal Observational Research in Atopic Dermatitis
NCT04240522 ·Status: RECRUITING
-
Efficacy and Safety Trial of ALK-depot SQ Mites in Subjects With Atopic Dermatitis
NCT00310492 ·Status: COMPLETED ·Phase: PHASE3
-
JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis
NCT03796676 ·Status: COMPLETED ·Phase: PHASE3
-
Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation
NCT05098821 ·Status: RECRUITING
-
Study of TER-101 Topical Ointment in Subjects With Atopic Dermatitis
NCT04753034 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Safety & Efficacy of Topical ATx201 OINTMENT in Adolescents and Adults With Mild to Moderate AD
NCT04339985 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis
NCT04921345 ·Status: COMPLETED ·Phase: PHASE2
-
Atopic Dermatitis Adherence Study
NCT02169986 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
NCT03422822 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Determine the Safety and Tolerability of Dupilumab (REGN668/SAR231893) in Patients Aged ≥6 to <18 Years With Atopic Dermatitis (Eczema)
NCT02407756 ·Status: COMPLETED ·Phase: PHASE2
-
Immunopharmacological Effects of Rituximab in Atopic Dermatitis
NCT00267826 ·Status: COMPLETED ·Phase: NA
-
The Factors Affecting Atopic Dermatitis in Children Age 1-3
NCT04218877 ·Status: COMPLETED
-
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
NCT06988605 ·Status: RECRUITING
-
Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic Dermatitis
NCT00148746 ·Status: COMPLETED ·Phase: NA
-
Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis
NCT03915496 ·Status: COMPLETED ·Phase: PHASE2
-
Microbiome in Atopic Dermatitis Under Systemic Therapy
NCT05099315 ·Status: RECRUITING
-
Collection of Clinical and Instrumental Data in Adult Subjects Suffering From Atopic Dermatitis
NCT04553224 ·Status: COMPLETED ·Phase: NA